These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9136827)

  • 21. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
    Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
    Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated cell-associated levels of interleukin 1beta and interleukin 6 in inflamed mucosa of inflammatory bowel disease.
    Grottrup-Wolfers E; Moeller J; Karbach U; Muller-Lissner S; Endres S
    Eur J Clin Invest; 1996 Feb; 26(2):115-22. PubMed ID: 8904520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of IL-16 in inflammatory bowel disease.
    Seegert D; Rosenstiel P; Pfahler H; Pfefferkorn P; Nikolaus S; Schreiber S
    Gut; 2001 Mar; 48(3):326-32. PubMed ID: 11171821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients.
    Brown KA; Back SJ; Ruchelli ED; Markowitz J; Mascarenhas M; Verma R; Piccoli DA; Baldassano RN
    Am J Gastroenterol; 2002 Oct; 97(10):2603-8. PubMed ID: 12385446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling.
    Koelink PJ; Bloemendaal FM; Li B; Westera L; Vogels EWM; van Roest M; Gloudemans AK; van 't Wout AB; Korf H; Vermeire S; Te Velde AA; Ponsioen CY; D'Haens GR; Verbeek JS; Geiger TL; Wildenberg ME; van den Brink GR
    Gut; 2020 Jun; 69(6):1053-1063. PubMed ID: 31506328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microscopic Colitis Evolved Into Inflammatory Bowel Diseases Is Characterized by Increased Th1/Tc1 Cells in Colonic Mucosal Lamina Propria.
    Li J; Yan Y; Meng Z; Liu S; Beck PL; Ghosh S; Qian J; Gui X
    Dig Dis Sci; 2017 Oct; 62(10):2755-2767. PubMed ID: 28597107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation.
    Autenrieth IB; Bucheler N; Bohn E; Heinze G; Horak I
    Gut; 1997 Dec; 41(6):793-800. PubMed ID: 9462212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mannose receptor (CD206) identifies a population of colonic macrophages in health and inflammatory bowel disease.
    Wright PB; McDonald E; Bravo-Blas A; Baer HM; Heawood A; Bain CC; Mowat AM; Clay SL; Robertson EV; Morton F; Nijjar JS; Ijaz UZ; Milling SWF; Gaya DR
    Sci Rep; 2021 Oct; 11(1):19616. PubMed ID: 34608184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation.
    Uo M; Hisamatsu T; Miyoshi J; Kaito D; Yoneno K; Kitazume MT; Mori M; Sugita A; Koganei K; Matsuoka K; Kanai T; Hibi T
    Gut; 2013 Dec; 62(12):1734-44. PubMed ID: 23013725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis.
    Kamada N; Hisamatsu T; Okamoto S; Chinen H; Kobayashi T; Sato T; Sakuraba A; Kitazume MT; Sugita A; Koganei K; Akagawa KS; Hibi T
    J Clin Invest; 2008 Jun; 118(6):2269-80. PubMed ID: 18497880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD).
    Rugtveit J; Bakka A; Brandtzaeg P
    Clin Exp Immunol; 1997 Oct; 110(1):104-13. PubMed ID: 9353156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease.
    Nishiyama T; Mitsuyama K; Toyonaga A; Sasaki E; Tanikawa K
    Digestion; 1994; 55(6):368-73. PubMed ID: 7705549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human intestinal pro-inflammatory CD11c
    Bernardo D; Marin AC; Fernández-Tomé S; Montalban-Arques A; Carrasco A; Tristán E; Ortega-Moreno L; Mora-Gutiérrez I; Díaz-Guerra A; Caminero-Fernández R; Miranda P; Casals F; Caldas M; Jiménez M; Casabona S; De la Morena F; Esteve M; Santander C; Chaparro M; Gisbert JP
    Mucosal Immunol; 2018 Jul; 11(4):1114-1126. PubMed ID: 29743615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.
    Reddy KP; Markowitz JE; Ruchelli ED; Baldassano RN; Brown KA
    Dig Dis Sci; 2007 Feb; 52(2):365-72. PubMed ID: 17219072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.
    Sato T; Kanai T; Watanabe M; Sakuraba A; Okamoto S; Nakai T; Okazawa A; Inoue N; Totsuka T; Yamazaki M; Kroczek RA; Fukushima T; Ishii H; Hibi T
    Gastroenterology; 2004 Mar; 126(3):829-39. PubMed ID: 14988837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of granulocyte-macrophage colony-stimulating factor treatment on phenotype, cytokine release and cytotoxicity of circulating blood monocytes and monocyte-derived macrophages.
    Hennemann B; Kreutz M; Rehm A; Andreesen R
    Br J Haematol; 1998 Sep; 102(5):1197-203. PubMed ID: 9753045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity.
    Smythies LE; Sellers M; Clements RH; Mosteller-Barnum M; Meng G; Benjamin WH; Orenstein JM; Smith PD
    J Clin Invest; 2005 Jan; 115(1):66-75. PubMed ID: 15630445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nerve growth factor regulation and production by macrophages in osteoarthritic synovium.
    Takano S; Uchida K; Inoue G; Miyagi M; Aikawa J; Iwase D; Iwabuchi K; Matsumoto T; Satoh M; Mukai M; Minatani A; Takaso M
    Clin Exp Immunol; 2017 Nov; 190(2):235-243. PubMed ID: 28677145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.